For the Inventor, By the Inventor

Enter assignee name

Tromsø, Norway

Biotec Pharmacon Asa

USPTO Granted Patents = 21

CIPO Patents = 2

EPO Patents = 8

Trademarks = 5

Forward Citations = 61

Loading Chart...

Loading Chart...

27 inventors (with patents filed for the assignee):

Rolf Einar Engstad (12 out of 20 patents)

Olav Lanes (6 out of 11 patents)

Rolf Seljelid (4 out of 4 patents)

4. Dag Rune Gjellesvik (3 out of 3 patents)

5. Bernd Fabry (3 out of 60 patents)

6. Rolf Wachter (3 out of 21 patents)

7. Ute Griesbach (3 out of 9 patents)

8. Nai-Kong V Cheung (2 out of 49 patents)

9. Terese Solstad (2 out of 5 patents)

10. Marit Sjo Lorentzen (2 out of 6 patents)

11. Morten Elde (2 out of 5 patents)

12. Thor Nøkland (2 out of 2 patents)

13. Gunnar Rorstad (2 out of 9 patents)

14. Bjørn Altermark (2 out of 3 patents)

15. Dag-Eirik Ramsøy (2 out of 3 patents)

21 patents: Sort by Forward Citations

1. 10646506 - Glucans (2020-05-12),

2. 9750688 - Glucan gels (2017-09-05),

3. 9650618 - Endonucleases (2017-05-16),

4. 9623043 - Glucans (2017-04-18),

5. 9422595 - Endonucleases (2016-08-23),

6. 9314432 - Glucan gels (2016-04-19),

7. 9211304 - Therapy-enhancing glucan (2015-12-15),

8. 9133447 - Method of removing nucleic acid contamination in reverse transcription and amplification reactions (2015-09-15),

9. 8946193 - Medical uses of glucans (2015-02-03),

10. 8912165 - Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents (2014-12-16),

11. 8551753 - Method of removing nucleic acid contamination in reverse transcription and amplification reactions (2013-10-08),

12. 8501710 - Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents (2013-08-06),

13. 8323644 - Therapy-enhancing glucan (2012-12-04),

14. 8142785 - Method or use of a solubilized glucan product to increase immunostimulation in animals (2012-03-27),

15. 7323325 - Shrimp alkaline phosphatase (2008-01-29),

Biotec Pharmacon ASA is a biotechnology company specializing in the development, production, and distribution of marine-based biopolymers and immunomodulators. With a focus on bioactive substances derived from Arctic marine organisms, Biotec Pharmacon aims to improve human and animal health. Through its subsidiaries, the company offers products for wound care, cancer treatment, and immune system regulation. Biotec Pharmacon is committed to creating innovative solutions that address global health challenges.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

21 Patents

#1 in Tromsø

#75 in Norway

#29,080 in the World

Tromsø, Norway

Biotec Pharmacon Asa

Forward Citations = 61

27 inventors:

Rolf Einar Engstad (12 out of 20 patents)

Olav Lanes (6 out of 11 patents)

Rolf Seljelid (4 out of 4 patents)

4. Dag Rune Gjellesvik (3 out of 3 patents)

5. Bernd Fabry (3 out of 60 patents)

Please report any incorrect information to support@idiyas.com

Loading…